Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Other Accumulated Expenses for 18 consecutive years, with $158.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses fell 9.26% year-over-year to $158.8 million in Q2 2026; TTM through Jun 2026 was $158.8 million, a 9.26% decrease from a year earlier, with the FY2025 full-year figure at $141.7 million, down 3.74% from the prior year.
• Other Accumulated Expenses was $158.8 million for Q2 2026 at Bio-Rad Laboratories, up from $153.9 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $212.7 million in Q2 2022 and troughed at $127.8 million in Q3 2025.
• A 5-year average of $159.9 million and a median of $156.4 million in 2026 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 37.29% in 2022 and retreated 21.85% in 2023, its largest moves.
• Over 5 years, Other Accumulated Expenses stood at $169.6 million in 2022, then decreased by 4.74% to $161.6 million in 2023, then dropped by 8.91% to $147.2 million in 2024, then declined by 3.74% to $141.7 million in 2025, then climbed by 12.07% to $158.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $158.8 million (Q2 2026), $153.9 million (Q1 2026), and $141.7 million (Q4 2025), per Business Quant data.